Muscle-sparing obesity drug safe for Phase 3 trial, Veru says
The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.


The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.